Company / Working Capital
iBio, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.6M
FY2025
5-year range
$3.6M / $98.0M
FY2021-FY2025
Trend
-12.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 4 consecutive years, from $98M in FY2021 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -42.3%.
Declined from $5M to $4M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -37.3%
- 5-Year CAGR
- -42.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- iBio, Inc.'s working capital has declined for 4 consecutive years.
- 5-year CAGR of -42.3%, indicating a declining trend.
- In FY2025, working capital decreased 12.9% year-over-year.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6M | -12.9% |
| FY2024 | $4.2M | -11.3% |
| FY2023 | $4.7M | -68.0% |
| FY2022 | $14.6M | -85.1% |
| FY2021 | $98.0M | +73.3% |
| FY2020 | $56.5M | +4086.1% |
| FY2019 | $1.4M | -90.5% |
| FY2018 | $14.3M | +117.3% |
| FY2017 | $6.6M | -69.7% |
| FY2016 | $21.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026